Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis
Open Access
- 18 December 2007
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 67 (11), 1596-1602
- https://doi.org/10.1136/ard.2007.079525
Abstract
Objectives: To investigate the expression of microsomal prostaglandin E (PGE) synthase 1 (mPGES-1) and cyclooxygenase (COX) in muscle biopsies from patients with polymyositis or dermatomyositis before and after conventional immunosuppressive treatment. Methods: mPGES-1 and COX expression was evaluated by immunohistochemistry in muscle tissue from healthy individuals and from patients with polymyositis or dermatomyositis before and after conventional immunosuppressive treatment. The number of inflammatory cell infiltrates, T lymphocytes and macrophages was estimated before and after treatment. To localise the mPGES-1 expression double immunofluorescence was performed with antibodies against mPGES-1, CD3, CD68, CD163 and a fibroblast marker. A functional index was used to assess muscle function. Results: In patients with myositis, mPGES-1, COX-2 and COX-1 expression was significantly higher compared to healthy individuals and associated with inflammatory cells. Double immunofluorescence demonstrated a predominant expression of mPGES-1 in macrophages. Conventional immunosuppressive treatment resulted in improved but still lower muscle function than normal. A decreased number of CD68-positive macrophages and reduced COX-2 expression in muscle tissue was also seen. By contrast, following the same treatment no significant changes were observed in muscle tissue regarding number of infiltrates, T lymphocytes, CD163-positive macrophages or mPGES-1 protein levels. Conclusions: Increased expression of mPGES-1, COX-1 and COX-2 at protein level was observed in muscle tissue from patients with myositis compared to healthy individuals. Conventional immunosuppressive treatment led to a significant downregulation of COX-2 in myositis muscle tissue. However, the expression of mPGES-1 and COX-1 remained unchanged indicating a role of these enzymes in the chronicity of these diseases.Keywords
This publication has 44 references indexed in Scilit:
- Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositisAnnals Of The Rheumatic Diseases, 2006
- COX-1 and COX-2 contribute differentially to the LPS-induced release of PGE2 and TxA2 in liver macrophagesProstaglandins & Other Lipid Mediators, 2006
- Stretch-induced myoblast proliferation is dependent on the COX2 pathwayExperimental Cell Research, 2005
- Differential expression and response to anti‐TNFα treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritisThe Journal of Pathology, 2005
- Role of cyclooxygenase‐1 and ‐2 in satellite cell proliferation, differentiation, and fusionMuscle & Nerve, 2004
- Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synoviumArthritis & Rheumatism, 2004
- Functional Coupling of Cyclooxygenase 1 and 2 to Discrete Prostanoid Synthases in Liver MacrophagesBiochemical and Biophysical Research Communications, 2000
- The role of hormones and prostanoids in the in vitro proliferation and differentiation of human myoblastsExperimental Cell Research, 1987
- Stimulation of Muscle Protein Degradation and Prostaglandin E2Release by Leukocytic Pyrogen (Interleukin-1)The New England Journal of Medicine, 1983
- Discriminators between neurotics who die and neurotics who liveActa Psychiatrica Scandinavica, 1979